Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant selection: proceedings from a TCA/SSRI Concensus Conference.

J Mendlewicz1, Y Lecrubier

  • 1Hopital Erasme, Service de Psychiatrie, Brussels, Belgium.

Acta Psychiatrica Scandinavica. Supplementum
|October 6, 2000
PubMed
Summary

Tricyclic antidepressants (TCAs) are no longer recommended as first-line treatment for depression. Selective serotonin reuptake inhibitors (SSRIs) offer varied profiles, making them a better choice for initial antidepressant selection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Acta psychiatrica Scandinavica·2018
Same author

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Pharmacological reviews·2018
Same author

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Acta psychiatrica Scandinavica·2018
Same author

Genetics of bipolar disorders.

Acta neuropsychiatrica·2016
Same author

Molecular genetic findings in mood disorders.

Acta neuropsychiatrica·2016
Same author

New molecular genetic findings in the genetics of affective disorders.

Acta neuropsychiatrica·2016

Area of Science:

  • Psychiatry and Mental Health
  • Pharmacology
  • Clinical Therapeutics

Background:

  • Antidepressant selection significantly impacts clinical outcomes in depression treatment.
  • Current antidepressant use in clinical practice is suboptimal.
  • Focus on initial antidepressant selection is crucial for improving patient prognosis.

Framework:

  • Systematic literature review on tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).
  • Expert panel convened to discuss and reach consensus on initial antidepressant selection.
  • Analysis of efficacy, tolerability, and breadth of indication for TCAs and SSRIs.

Implementation:

  • TCAs are generally not justified as first-line therapy in most clinical settings.
  • Emerging differences in SSRI tolerability profiles are critical considerations.

Related Experiment Videos

  • SSRIs offer a broader range of indications compared to TCAs.

    • Implications:

    • Informed initial antidepressant choices can improve clinical outcomes for depression.
    • Enhanced antidepressant selection can positively influence the long-term prognosis of depression.
    • Clinicians can optimize antidepressant treatment quality with current options.